Cell Bio Human Tech Co.,Ltd (KOSDAQ:318160)

KOSDAQ:318160 Revenue

Cell Bio Human Tech Co.,Ltd had revenue of 19.36B KRW in the quarter ending June 30, 2026, with 38.43% growth. This brings the company's total for the last twelve months to 60.90B, up 61.93% year-over-year. In the year 2025, Cell Bio Human Tech Co.,Ltd had annual revenue of 51.07B with 79.69% growth. That makes Cell Bio Human Tech Co.,Ltd the 28,643rd largest company in the world by revenue and 1,755th in South Korea.

• Revenue (ttm): 60.90B
• Revenue Growth: +61.93%
• P/S Ratio: 0.87
• Revenue / Employee: 529.57M
• Employees: 115
• Market Cap: 53.16B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• South Korea 46.94B 59.3%
• Asia 32.21B 40.7%
• America 54.10M 0.1%

Fiscal year ended Dec 31, 2025 See the full KOSDAQ:318160 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	51.07B	22.65B	79.69%
Dec 31, 2024	28.42B	1.09B	4.01%
Dec 31, 2023	27.32B	-220.33M	-0.80%
Dec 31, 2022	27.54B	-7.62B	-21.66%
Dec 31, 2021	35.16B	6.57B	22.99%

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 28, 2026

Data Sources Report a data error